Twelve reviews the results of the Q2 2018 reporting season for US life insurers and the overall valuation of these companies. Analysis shows valuations seem to be pricing in pessimism which is neither justified by company-specific fundamentals nor the overall current macro environment.
This Twelve Capital Research Spotlight focuses on the current opportunity in the US life insurance sector. To download your copy, please click here.
Thursday, 30 August 2018
